Clinical outcomes of corticosteroids for COVID-19 patients at the National Center for Global Health and Medicine during the first wave of infections

BACKGROUND: Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2, has been a significant concern worldwide since its outbreak in December 2019. Various treatments are being researched and developed, and there are reports that dexamethasone has reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Morita, Chie, Suzuki, Manabu, Izumi, Shinyu, Tsukada, Akinari, Tsujimoto, Yoshie, Sakamoto, Keita, Hashimoto, Masao, Takasaki, Jin, Ohmagari, Norio, Hojo, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Respiratory Society. Published by Elsevier B.V. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616739/
https://www.ncbi.nlm.nih.gov/pubmed/34872886
http://dx.doi.org/10.1016/j.resinv.2021.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616739/
https://www.ncbi.nlm.nih.gov/pubmed/34872886
http://dx.doi.org/10.1016/j.resinv.2021.11.001

Ejemplares similares